(Q31864713)

English

Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

6

object named as

P Devroey

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

author name string

M Ludwig

1

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

H Riethmüller-Winzen

2

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

R E Felberbaum

3

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

F Olivennes

4

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

C Albano

5

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

K Diedrich

7

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

language of work or name

0 references

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Fertility and Sterility

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

75

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

18-22

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901632-0

7 January 2021

Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist Cetrorelix at different dosages

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901632-0

7 January 2021

First established pregnancy after controlled ovarian hyperstimulation with recombinant follicle stimulating hormone and the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462)

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901632-0

7 January 2021

The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901632-0

7 January 2021

The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901632-0

7 January 2021

Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901632-0

7 January 2021

Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901632-0

7 January 2021

Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901632-0

7 January 2021

Assisted reproductive technology in the United States and Canada: 1995 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901632-0

7 January 2021

Complications of medically assisted conception in 3,500 cycles

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901632-0

7 January 2021

Obstetric outcome of 424 pregnancies after intracytoplasmic sperm injection

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901632-0

7 January 2021

Obstetric outcome of 904 pregnancies after intracytoplasmic sperm injection

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901632-0

7 January 2021

Identifiers

10.1016/S0015-0282(00)01632-0

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31864713&oldid=1953423415"